443986-73-0 Usage
1H-Pyrrolo[2,3-b]pyridine-2,3-dione core structure
The compound has a core structure that consists of a pyrrolopyridine ring system, with one carbonyl group at the 2-position and one carbonyl group at the 3-position.
Oxime functional group
The compound has an oxime functional group attached to the 3-position of the core structure, which can potentially form coordination bonds with metal ions and participate in hydrogen bonding interactions.
Triphenylmethyl moiety
The compound has a triphenylmethyl group attached to the oxime functional group, which provides stability to the molecule and facilitates its isolation and purification.
Potential medicinal properties
As a derivative of pyrrolopyridine, the compound has potential medicinal properties that can be explored in research and pharmaceutical development.
Possible applications in oncology and neurology
The unique structure and biological activity of the compound may make it useful in the development of new drugs for the treatment of cancer and neurological disorders.
Need for further research
Further studies are needed to fully understand the potential uses and effects of the compound.
Check Digit Verification of cas no
The CAS Registry Mumber 443986-73-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,3,9,8 and 6 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 443986-73:
(8*4)+(7*4)+(6*3)+(5*9)+(4*8)+(3*6)+(2*7)+(1*3)=190
190 % 10 = 0
So 443986-73-0 is a valid CAS Registry Number.
443986-73-0Relevant academic research and scientific papers
Respiratory syncytial virus fusion inhibitors. Part 7: Structure-activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo
Sin, Ny,Venables, Brian L.,Combrink, Keith D.,Gulgeze, H. Belgin,Yu, Kuo-Long,Civiello, Rita L.,Thuring, Jan,Wang, X. Alan,Yang, Zheng,Zadjura, Lisa,Marino, Anthony,Kadow, Kathleen F.,Cianci, Christopher W.,Clarke, Junius,Genovesi, Eugene V.,Medina, Ivette,Lamb, Lucinda,Krystal, Mark,Meanwell, Nicholas A.
scheme or table, p. 4857 - 4862 (2010/04/29)
A series of bezimidazole-isatin oximes were prepared and profiled as inhibitors of respiratory syncytial virus (RSV) replication in cell culture. Structure-activity relationship studies were directed toward optimization of antiviral activity, cell permeab
